{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:53Z","timestamp":1786984313375,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.anai.2022.07.016","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:16:21Z","timestamp":1659168981000},"page":"776-783.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency"],"prefix":"10.1016","volume":"129","author":[{"given":"Nicholas","family":"Hartog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Michniacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Holsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Hurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Fredrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Walkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2022.07.016_bib0001","unstructured":"Michigan Department of Health and Human Services. Michigan.gov. Mdhhs. Vol. 2021. Available at: https:\/\/www.michigan.gov\/mdhhs\/adult-child-serv\/childrenfamilies\/hereditary\/newborn-screening----list-of-disorders. Accessed November 1, 2021."},{"key":"10.1016\/j.anai.2022.07.016_bib0002","unstructured":"Health Resources and Services Administration. Newborn screening information center. 2021. Available at: https:\/\/newbornscreening.hrsa.gov\/. Accessed November 1, 2021."},{"issue":"1","key":"10.1016\/j.anai.2022.07.016_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.gendis.2019.07.004","article-title":"Genetics of severe combined immunodeficiency","volume":"7","author":"Kumrah","year":"2020","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.anai.2022.07.016_bib0004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.016_bib0005","article-title":"Clinical, immunological, and molecular features of severe combined immune deficiency: a multi-institutional experience from India","volume":"11","author":"Vignesh","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2022.07.016_bib0007","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/1744666X.2017.1381558","article-title":"Long term outcomes of severe combined immunodeficiency: therapy implications","volume":"13","author":"Heimall","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.07.016_bib0008","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anai.2022.07.016_bib0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.anai.2022.07.016_bib0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2022.07.016_bib0011","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaci.2017.01.005","article-title":"Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening","volume":"139","author":"Dorsey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0012","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","article-title":"SCID newborn screening: what we've learned","volume":"147","author":"Currier","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.016_bib0013","unstructured":"Hershfield M. Adenosine deaminase deficiency. 2017. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1483\/. Accessed November 1, 2021."},{"issue":"1","key":"10.1016\/j.anai.2022.07.016_bib0014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004390050460","article-title":"Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes","volume":"100","author":"Hirschhorn","year":"1997","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.anai.2022.07.016_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.anai.2022.07.016_bib0016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.anai.2022.07.016_bib0017","doi-asserted-by":"crossref","unstructured":"Cuvelier GDE, Logan BR, Prockop S, Buckley RH, Kuo CY, Griffith LM, et al. Outcomes following treatment for adenosine deaminase deficient severe combined immunodeficiency: a report from the PIDTC [e-pub ahead of print]. Blood. https:\/\/doi.org\/10.1182\/blood.2022016196. Accessed June 15, 2022.","DOI":"10.1182\/blood.2022016196"},{"issue":"6","key":"10.1016\/j.anai.2022.07.016_bib0018","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaci.2012.08.054","article-title":"Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency","volume":"131","author":"la Marca","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.07.016_bib0019","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaci.2011.03.040","article-title":"Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry","volume":"127","author":"Azzari","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2300","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017","volume":"143","author":"Amatuni","year":"2019","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.anai.2022.07.016_bib0021","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-005579","article-title":"Delayed-onset ADA1 (ADA) deficiency not detected by TREC screen","volume":"147","author":"Kahwash","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.anai.2022.07.016_bib0022","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2011.12.004","article-title":"The Wisconsin approach to newborn screening for severe combined immunodeficiency","volume":"129","author":"Verbsky","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.016_bib0023","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaci.2012.04.004","article-title":"Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis","volume":"130","author":"Speckmann","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.016_bib0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpba.2014.03.047","article-title":"Mass spectrometry in clinical chemistry: the case of newborn screening","volume":"101","author":"la Marca","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1524-4733.2006.00156.x","article-title":"The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model","volume":"10","author":"Cipriano","year":"2007","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.anai.2022.07.016_bib0026","doi-asserted-by":"crossref","DOI":"10.3310\/hta8120","article-title":"Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review","volume":"8","author":"Pandor","year":"2004","journal-title":"Health Technol Assess"},{"issue":"5 Pt 2","key":"10.1016\/j.anai.2022.07.016_bib0027","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1542\/peds.2005-2633G","article-title":"Economic evaluation of tandem mass spectrometry screening in California","volume":"117","author":"Feuchtbaum","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0028","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1172\/JCI114730","article-title":"Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency","volume":"86","author":"Arredondo-Vega","year":"1990","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.anai.2022.07.016_bib0029","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1016\/S0021-9258(20)65152-3","article-title":"Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells","volume":"257","author":"Hershfield","year":"1982","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2020.12.633","article-title":"An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity","volume":"147","author":"King","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.016_bib0031","first-page":"281","article-title":"[Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"issue":"3","key":"10.1016\/j.anai.2022.07.016_bib0032","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4049\/jimmunol.166.3.1698","article-title":"Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency","volume":"166","author":"Ariga","year":"2001","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.anai.2022.07.016_bib0033","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood.V97.9.2896","article-title":"T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation","volume":"97","author":"Ariga","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anai.2022.07.016_bib0034","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00431-009-1131-9","article-title":"Late-onset adenosine deaminase deficiency presenting with Heck's disease","volume":"169","author":"Artac","year":"2010","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2022.07.016_bib0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2011.08640.x","article-title":"ADA-SCID with \u2018WAZA-ARI\u2019 mutations that synergistically abolished ADA protein stability","volume":"153","author":"Okura","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.016_bib0036","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0037","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI116626","article-title":"T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase","volume":"92","author":"Weinberg","year":"1993","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.anai.2022.07.016_bib0038","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-017-0421-7","article-title":"Long-term outcome of adenosine deaminase-deficient patients-a single-center experience","volume":"37","author":"Scott","year":"2017","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.016_bib0039","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","volume":"38","author":"Cagdas","year":"2018","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.016_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.07.016_bib0041","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.1001770","article-title":"The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency","volume":"185","author":"Serana","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.016_bib0042","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2169","article-title":"A 24-year enzyme replacement therapy in an adenosine-deaminase-deficient patient","volume":"137","author":"Tartibi","year":"2016","journal-title":"Pediatrics"},{"issue":"17","key":"10.1016\/j.anai.2022.07.016_bib0043","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"issue":"5235","key":"10.1016\/j.anai.2022.07.016_bib0044","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"issue":"5235","key":"10.1016\/j.anai.2022.07.016_bib0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.anai.2022.07.016_bib0046","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0798-775","article-title":"T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates","volume":"4","author":"Kohn","year":"1998","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.anai.2022.07.016_bib0047","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2016-01-688226","article-title":"Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"128","author":"Cicalese","year":"2016","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.anai.2022.07.016_bib0048","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2012-02-400937","article-title":"Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans","volume":"120","author":"Candotti","year":"2012","journal-title":"Blood"},{"issue":"97","key":"10.1016\/j.anai.2022.07.016_bib0049","doi-asserted-by":"crossref","first-page":"97ra80","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.anai.2022.07.016_bib0050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1172\/JCI90367","article-title":"Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency","volume":"127","author":"Shaw","year":"2017","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.anai.2022.07.016_bib0051","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2022.07.016_bib0052","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2017.07.002","article-title":"Idiopathic T cell lymphopenia identified in New York State newborn Screening","volume":"183","author":"Albin-Leeds","year":"2017","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.016_bib0053","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10875-020-00957-6","article-title":"Characterization of infants with idiopathic transient and persistent T cell lymphopenia identified by newborn screening-a single-center experience in New York State","volume":"41","author":"Jongco","year":"2021","journal-title":"J Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062200610X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062200610X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:32Z","timestamp":1761053432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112062200610X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S108112062200610X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.07.016","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}